NZ180946A - 6 -fluoro-11 ,21-dihydroxy-16 ,17 -isopropylidenedi-oxy-pregna-1,4-dien-3,20-dione having polymorphic form-form a - Google Patents

6 -fluoro-11 ,21-dihydroxy-16 ,17 -isopropylidenedi-oxy-pregna-1,4-dien-3,20-dione having polymorphic form-form a

Info

Publication number
NZ180946A
NZ180946A NZ180946A NZ18094676A NZ180946A NZ 180946 A NZ180946 A NZ 180946A NZ 180946 A NZ180946 A NZ 180946A NZ 18094676 A NZ18094676 A NZ 18094676A NZ 180946 A NZ180946 A NZ 180946A
Authority
NZ
New Zealand
Prior art keywords
isopropylidenedi
pregna
dien
dione
dihydroxy
Prior art date
Application number
NZ180946A
Other languages
English (en)
Inventor
G Haringer
R Jones
H Fried
Original Assignee
Syntex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex Inc filed Critical Syntex Inc
Priority to NZ183905A priority Critical patent/NZ183905A/xx
Publication of NZ180946A publication Critical patent/NZ180946A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/0026—Oxygen-containing hetero ring cyclic ketals
    • C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
NZ180946A 1975-05-27 1976-05-25 6 -fluoro-11 ,21-dihydroxy-16 ,17 -isopropylidenedi-oxy-pregna-1,4-dien-3,20-dione having polymorphic form-form a NZ180946A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NZ183905A NZ183905A (en) 1975-05-27 1976-05-25 Aerosol compositions for nasal or inhalation administration containing 6 -fluoro-11 , 21-dihydroxy-16 ,17 -isopropylidenedioxy-pregna-1,4-diene-3,20-dione

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58130075A 1975-05-27 1975-05-27
US58130175A 1975-05-27 1975-05-27

Publications (1)

Publication Number Publication Date
NZ180946A true NZ180946A (en) 1978-07-28

Family

ID=27078279

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ180946A NZ180946A (en) 1975-05-27 1976-05-25 6 -fluoro-11 ,21-dihydroxy-16 ,17 -isopropylidenedi-oxy-pregna-1,4-dien-3,20-dione having polymorphic form-form a

Country Status (15)

Country Link
JP (1) JPS51144719A (enrdf_load_html_response)
AT (1) AT357702B (enrdf_load_html_response)
AU (1) AU506080B2 (enrdf_load_html_response)
CA (1) CA1075228A (enrdf_load_html_response)
DE (2) DE2661037C2 (enrdf_load_html_response)
ES (1) ES448220A1 (enrdf_load_html_response)
FR (1) FR2361900A1 (enrdf_load_html_response)
GB (1) GB1525181A (enrdf_load_html_response)
HK (1) HK8580A (enrdf_load_html_response)
IL (1) IL49652A (enrdf_load_html_response)
MX (1) MX3864E (enrdf_load_html_response)
MY (1) MY8000275A (enrdf_load_html_response)
NL (1) NL191234C (enrdf_load_html_response)
NZ (1) NZ180946A (enrdf_load_html_response)
SE (1) SE421426B (enrdf_load_html_response)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2457303A1 (fr) * 1979-05-21 1980-12-19 Syntex Corp Procede de preparation d'une forme cristalline de flunisolide, le produit obtenu et son utilisation comme produit pharmaceutique
ATE3774T1 (de) * 1980-05-02 1983-06-15 Schering Corporation Beclomethason-ester-solvate, verfahren zu ihrer herstellung und herstellung einer formulierung.
GB2127689B (en) * 1982-10-05 1986-07-09 Sandoz Ltd Calcitonin inhalation compositions
US4782047A (en) * 1986-05-22 1988-11-01 Syntex Pharmaceuticals International Ltd. Aqueous steroid formulations for nasal administration
US5707634A (en) * 1988-10-05 1998-01-13 Pharmacia & Upjohn Company Finely divided solid crystalline powders via precipitation into an anti-solvent
DE68907062T2 (de) * 1988-10-05 1993-10-07 Upjohn Co Feinverteiltes feste kristalline pulver durch niederschlag in einem anti-lösungsmittel.
DE4003272A1 (de) 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgasmischungen und ihre verwendung in arzneimittelzubereitungen
UA62917C2 (en) * 1995-06-27 2004-01-15 Berinher Inhelheim Kg Medicinal composition for generating propellant-free aerosols
DE19653969A1 (de) * 1996-12-20 1998-06-25 Boehringer Ingelheim Kg Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole
US20010031244A1 (en) 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
DZ2947A1 (fr) 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
EP2340865B1 (en) * 1999-03-03 2016-07-20 Optinose AS Nasal delivery device
IT1313553B1 (it) * 1999-07-23 2002-09-09 Chiesi Farma Spa Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
IT1317846B1 (it) 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
AU2000250701B2 (en) 2000-05-22 2004-07-01 Chiesi Farmaceutici S.P.A. Stable pharmaceutical solution formulations for pressurised metered dose inhalers
DE60103527T2 (de) 2001-07-02 2005-06-16 Chiesi Farmaceutici S.P.A. Optimierte Tobramycin-Formulierung zur Aerosolbildung
JP4632687B2 (ja) * 2003-04-25 2011-02-16 ロート製薬株式会社 点鼻剤
JP5238779B2 (ja) * 2003-04-25 2013-07-17 ロート製薬株式会社 点鼻剤
EP1595531A1 (en) 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stable pharmaceutical solution formulations for pressurized metered dose inhalers
CN105188758A (zh) 2013-03-15 2015-12-23 梅迪奇斯医药公司 氟尼缩松的局部组合物及治疗方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3126375A (en) 1964-03-24 Chioacyl
GB933868A (en) * 1958-12-08 1963-08-14 American Cyanamid Co Process for fluorinating steroids
US3282791A (en) 1965-08-17 1966-11-01 Merck & Co Inc Inhalation aerosol suspension of anhydrous disodium dexamethasone phosphate, propellents, and sorbitan trioleate
US3592930A (en) 1968-07-19 1971-07-13 Syntex Corp Moisture-deterioratable topical medicaments,particularly anti-inflammatory steroids,in a substantially non-aqueous fatty alcohol-propylene glycol vehicle
FR2038105A1 (fr) * 1969-04-01 1971-01-08 Syntex Corp Composition anti-inflammatoire locale et son mode d'utilisation
GB1429184A (en) * 1972-04-20 1976-03-24 Allen & Hanburys Ltd Physically anti-inflammatory steroids for use in aerosols
DE2332663C2 (de) 1973-06-23 1986-07-31 Schering AG, 1000 Berlin und 4709 Bergkamen Verwendung von Kortikoid-Wirkstoffen zur Inhalationstherapie
US3934013A (en) * 1975-02-21 1976-01-20 Syntex (U.S.A.) Inc. Pharmaceutical composition

Also Published As

Publication number Publication date
ES448220A1 (es) 1977-11-01
IL49652A (en) 1979-05-31
NL191234B (nl) 1994-11-01
DE2624924A1 (de) 1977-12-15
SE7605927L (sv) 1976-11-28
FR2361900A1 (fr) 1978-03-17
IL49652A0 (en) 1976-07-30
AT357702B (de) 1980-07-25
MX3864E (es) 1981-08-26
JPS51144719A (en) 1976-12-13
JPS6247880B2 (enrdf_load_html_response) 1987-10-09
MY8000275A (en) 1980-12-31
SE421426B (sv) 1981-12-21
DE2624924C2 (de) 1986-11-27
AU506080B2 (en) 1979-12-13
FR2361900B1 (enrdf_load_html_response) 1979-04-13
DE2661037C2 (enrdf_load_html_response) 1989-04-06
NL7605699A (nl) 1976-11-30
NL191234C (nl) 1995-04-03
CA1075228A (en) 1980-04-08
ATA388376A (de) 1979-12-15
AU1430176A (en) 1977-12-01
GB1525181A (en) 1978-09-20
HK8580A (en) 1980-03-14

Similar Documents

Publication Publication Date Title
NZ180946A (en) 6 -fluoro-11 ,21-dihydroxy-16 ,17 -isopropylidenedi-oxy-pregna-1,4-dien-3,20-dione having polymorphic form-form a
AU522854B2 (en) Corticoid 17-(alkyl-carbonates
AU497043B2 (en) Pincers
AU2047276A (en) 9 21-dihalogeno-11 17 -dihydroxy-6 -fluro-16-methyl-pregna-1,4-diene-3,20-diones
AU500942B2 (en) 15 steroids
NZ181482A (en) Androsta-4 , 16-dien-3-ones
JPS5350152A (en) Pregnane derivatives
GB1557682A (en) Pincers
JPS52148062A (en) Steroids
AU512101B2 (en) 19-oxygenated steroids
AU499988B2 (en) Androstane derivatives
GB1543907A (en) Steroid compositions
GB1536691A (en) 16-methyl-17-bromo-1,4-pregnadien-21-ol-3,20-dione compounds
HU179593B (en) Process for producing 9-alpha-chloro-11-beta,17-dihydroxy-pregna-1,4-diene-3,20-dione derivatives
AU505624B2 (en) B-homo steroids
NZ183817A (en) 13-alkyl-d-homogono-4,16-dien-3 ,17 -diol derivatives
AU1522976A (en) 20-cyano-20,21-epoxy steroids
NZ182356A (en) D-homopregna-1,4-diene -3,ii,20-triones
JPS51118181A (en) Rotaing chuck
JPS5297957A (en) Novel steroid compound
JPS51141881A (en) Steroids
NZ182865A (en) 2.9 -dichloro-6 -fluoro-16 -methyl-11 ,17 , 21-trihydroxy-pregna-1,4-diene-3,20-diones
AU523556B2 (en) Pregnane derivatives
ZA774666B (en) 21,21-dihalo steroids
AU1067676A (en) Steroids